Du Lingbin, Li Runhua, Ge Minghua, Wang Youqing, Li Huizhang, Chen Wanqing, He Jie
Zhejiang Cancer Center, Zhejiang Cancer Hospital, Hangzhou 310022, China.
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100021, China.
Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09.
To analyze the incidence and mortality rates of thyroid cancer (TC) in China from 2008 to 2012.
Incident and death cases of TC were retrieved from the National Central Cancer Registry (NCCR) database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of TC were calculated by area (urban/rural), region (eastern, middle, western), gender and age group (0, 1-4, 5-9, …, 85+). China census in 2000 and world Segi's population were applied for age-standardized rates. Joinpoint (Version 4.6.0.0) model was used for time-trend analysis.
The crude incidence rate of TC was 7.56/100,000 which ranked the seventh in overall cancers. The age-standardized incidence rates by China population (ASIRC) and by World population (ASIRW) were 6.25/100,000 and 5.52/100,000, respectively. The crude mortality of TC in China was 0.52/100,000. The age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 0.34/100,000 and 0.32/100,000, respectively. Incidence and mortality rates of TC were higher in females than in males and higher in urban areas than in rural areas. Eastern areas had the highest incidence followed by middle and western areas. TC incidence increased dramatically after age of 15 years, then peaked at 14.08/100,000 in the group of 50-54 years and finally decreased sharply after 55 years old. TC mortality increased with age in population, reaching the peak of 5.09/100,000 in sub-population aged 85 years or older. TC incidence increased by 4.73 times from 2.40/100,000 in 2003 to 13.75/100,000 in 2012 with an average annual increase of 20%, while TC mortality only increased slightly around 0.32/100,000 from 0.26/100,000 to 0.36/100,000.
Appropriate targeted prevention, early detection and treatment programs can be carried out to curb the rapid growth trend of TC and control the disease burden.
分析2008年至2012年中国甲状腺癌(TC)的发病率和死亡率。
从国家癌症中心登记处(NCCR)数据库中检索2008 - 2012年期间中国135个癌症登记处收集的TC发病和死亡病例。按地区(城市/农村)、区域(东部、中部、西部)、性别和年龄组(0、1 - 4、5 - 9、…、85岁及以上)计算TC的粗发病率和死亡率。采用2000年中国人口普查数据和世界Segi人口数据计算年龄标准化率。使用Joinpoint(版本4.6.0.0)模型进行时间趋势分析。
TC的粗发病率为7.56/10万,在所有癌症中排名第七。按中国人口计算的年龄标准化发病率(ASIRC)和按世界人口计算的年龄标准化发病率(ASIRW)分别为6.25/10万和5.52/10万。中国TC的粗死亡率为0.52/10万。按中国标准人口计算的年龄标准化死亡率(ASMRC)和按世界标准人口计算的年龄标准化死亡率(ASMRW)分别为0.34/10万和0.32/10万。TC的发病率和死亡率女性高于男性,城市地区高于农村地区。东部地区发病率最高,其次是中部和西部地区。TC发病率在15岁后急剧上升,然后在50 - 54岁年龄组达到峰值14.08/10万,55岁后急剧下降。TC死亡率随年龄增长而上升,在85岁及以上人群中达到峰值5.09/10万。TC发病率从2003年的2.40/10万增加到2012年的13.75/10万,增长了4.73倍,年均增长20%,而TC死亡率仅从0.26/10万略有增加到0.36/10万左右,约为0.32/10万。
可开展适当的针对性预防、早期检测和治疗项目,以遏制TC的快速增长趋势并控制疾病负担。